Long-Term Success in the Management of an Extensive Medial Canthal Basal-Cell Carcinoma with Vismodegib
Purpose: To present a case of an extensive basal-cell carcinoma (BCC) of the medial canthus that was successfully treated with vismodegib. The introduction of vismodegib and other Hedgehog pathway inhibitors into clinical practice has provided a new option for the nonsurgical management of periocula...
Saved in:
| Main Authors: | Argyrios Tzamalis, Georgios Lavasidis, Ioannis Tsinopoulos, Nikolaos Ziakas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | Journal of Current Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/joco.joco_76_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
by: Z. A.-G. Radzhabova, et al.
Published: (2020-02-01) -
Vismodegib for the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
by: Concetta Laliscia, et al.
Published: (2019-12-01) -
Modern methods of treatment of locally-advanced and recurrent basal cell carcinoma of the head and neck with using signal pathway inhibitor Hedgehog: сlinical cases
by: A. P. Polyakov, et al.
Published: (2019-04-01) -
Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
by: Bingqing Wang, et al.
Published: (2025-05-01) -
Clinical features, pathology, and surgical management of periocular giant basal cell carcinoma
by: Oxana Madalina Grosu, et al.
Published: (2020-10-01)